Publication Cover
Nutritional Neuroscience
An International Journal on Nutrition, Diet and Nervous System
Latest Articles
85
Views
0
CrossRef citations to date
0
Altmetric
Review Article

Fruits and vegetables intake may be associated with a reduced odds of multiple sclerosis: a systematic review and dose–response meta-analysis of observational studies

, , &

References

  • Estruch R, Ros E, Salas-Salvadó J, Covas MI, Corella D, Arós F, et al. Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts. N Engl J Med. 2018;378(25):e34.
  • Lewis ED, Meydani SN, Wu D. Regulatory role of vitamin E in the immune system and inflammation. IUBMB Life. 2019;71(4):487–94.
  • Ransohoff RM, Hafler DA, Lucchinetti CF. Multiple sclerosis—a quiet revolution. Nat Rev Neurol. 2015;11(3):134–42.
  • Prasad AS. Zinc: an antioxidant and anti-inflammatory agent: role of zinc in degenerative disorders of aging. J Trace Elem Med Biol. 2014;28(4):364–71.
  • Hartung H-P, Archelos JJ, Zielasek J, Gold R, Koltzenburg M, Reiners K-H, et al. Circulating adhesion molecules and inflammatory mediators in demyelination: a review. Neurology. 1995;45(6 Suppl 6):S22–S32.
  • Hauser S, Doolittle T, Lincoln R, Brown R, Dinarello C. Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6. Neurology. 1990;40(11):1735.
  • Hofman F, Hinton D, Johnson K, Merrill J. Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med. 1989;170(2):607–12.
  • Rudick RA, Ransohoff RM. Cytokine secretion by multiple sclerosis monocytes: relationship to disease activity. Arch Neurol. 1992;49(3):265–70.
  • Sharief MK, Hentges R. Association between tumor necrosis factor-α and disease progression in patients with multiple sclerosis. N Engl J Med. 1991;325(7):467–72.
  • Trotter JL, Collins KG, van der Veen RC. Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-α levels. J Neuroimmunol. 1991;33(1):29–36.
  • Ishihara A, Ishihara J, Watkins EA, Tremain AC, Nguyen M, Solanki A, et al. Prolonged residence of an albumin–IL-4 fusion protein in secondary lymphoid organs ameliorates experimental autoimmune encephalomyelitis. Nat Biomed Eng. 2021;5(5):387–98.
  • Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol. 1998;16:137–61.
  • Ozenci V, Kouwenhoven M, Huang Y, Xiao B, Kivisakk P, Fredrikson S, et al. Multiple sclerosis: levels of interleukin-10-secreting blood mononuclear cells are low in untreated patients but augmented during interferon-b-1b treatment. Scand J Immunol. 1999;49(5):554–61.
  • Wiesemann E, Klatt J, Wenzel C, Heidenreich F, Windhagen A. Correlation of serum IL-13 and IL-5 levels with clinical response to Glatiramer acetate in patients with multiple sclerosis. Clin Exp Immunol. 2003;133(3):454–60.
  • Dyment DA, Sadnovich AD, Ebers GC. Genetics of multiple sclerosis. Hum Mol Genet. 1997;6(10):1693–8.
  • Sadovnick AD, Dyment D, Ebers G. Genetic epidemiology of multiple sclerosis. Epidemiol Rev. 1997;19(1):99–106.
  • Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part II: noninfectious factors. Annals of Neurol: Off J Am Neurol Assoc Child Neurol Soc. 2007;61(6):504–13.
  • Axthelm MK, Bourdette DN, Marracci GH, Su W, Mullaney ET, Manoharan M, et al. Japanese macaque encephalomyelitis: a spontaneous multiple sclerosis–like disease in a nonhuman primate. Ann Neurol. 2011;70(3):362–73.
  • Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci USA. 2017;114(30):10713–8.
  • de Abreu DF, Babron IM, Rebeix C, Fontenille J, Yaouanq D, Brassat B, et al. Season of birth and not vitamin D receptor promoter polymorphisms is a risk factor for multiple sclerosis. Mult Scler J. 2009;15(10):1146–52.
  • Templer D, Trent N, Spencer D, Trent A, Corgiat M, Mortensen P, et al. Season of birth in multiple sclerosis. Acta Neurol Scand. 1992;85(2):107–9.
  • Cobo-Cuenca AI, Garrido-Miguel M, Soriano-Cano A, Ferri-Morales A, Martínez-Vizcaíno V, Martín-Espinosa NM. Adherence to the Mediterranean diet and its association with body composition and physical fitness in Spanish university students. Nutrients. 2019;11(11):2830.
  • Zimmermann C, Wagner AE. Impact of food-derived bioactive compounds on intestinal immunity. Biomolecules. 2021;11(12):1901.
  • Wastyk HC, Fragiadakis GK, Perelman D, Dahan D, Merrill BD, Feiqiao BY, et al. Gut-microbiota-targeted diets modulate human immune status. Cell. 2021;184(16):4137-53–e14.
  • Esposito S, Sparaco M, Maniscalco G, Signoriello E, Lanzillo R, Russo C, et al. Lifestyle and Mediterranean diet adherence in a cohort of southern Italian patients with multiple sclerosis. Mult Scler Relat Disord. 2021;47:102636.
  • Noormohammadi M, Ghorbani Z, Naser Moghadasi A, Saeedirad Z, Shahemi S, Ghanaatgar M, et al. Mind diet adherence might be associated with a reduced odds of multiple sclerosis: results from a case-control study. Neurol Ther. 2022;11(1):397–412.
  • Hoseini Z, Behrooz M, Houshyar-rad A, Askari otaghvari S, Asadi H, Nematy M. The relationship between fruit and vegetable consumption and Multiple Sclerosis: a case –control study. North Khorasan Univ Med Sci. 2016;7(3):573–84.
  • Altowaijri G, Fryman A, Yadav V. Dietary interventions and multiple sclerosis. Curr Neurol Neurosci Rep. 2017;17(3):28.
  • Asghari G, Rezazadeh A, Hosseini-Esfahani F, Mehrabi Y, Mirmiran P, Azizi F. Reliability, comparative validity and stability of dietary patterns derived from an FFQ in the Tehran Lipid and Glucose Study. Br J Nutr. 2012;108(6):1109–17.
  • Ghadirian P, Jain M, Ducic S, Shatenstein B, Morisset R. Nutritional factors in the aetiology of multiple sclerosis: a case-control study in Montreal, Canada. Int J Epidemiol. 1998;27(5):845–52.
  • Bagheri M, Maghsoudi Z, Fayazi S, Elahi N, Tabesh H, Majdinasab N. Several food items and multiple sclerosis: a case-control study in Ahvaz (Iran). Iran J Nurs Midwifery Res. 2014;19(6):659–65.
  • Sedaghat F, Jessri M, Behrooz M, Mirghotbi M, Rashidkhani B. Mediterranean diet adherence and risk of multiple sclerosis: a case-control study. Asia Pac J Clin Nutr. 2016;25(2):377–84.
  • Al Wutayd O, Mohamed AG, Saeedi J, Al Otaibi H, Al Jumah M. Environmental exposures and the risk of multiple sclerosis in Saudi Arabia. BMC Neurol. 2018;18(1):86.
  • Ghazavi Y, Bahadoran Z, Nikfarjam M, Moghaddam NB, Mirmiran P, Heydari MR. Comparison of food intake in multiple sclerosis patients and healthy individuals: a hospital-based case-controlled study. Iran J Child Neurol. 2019;13(4):143–54.
  • Rezaeimanesh N, Moghadasi AN, Sahraian MA, Eskandarieh S. Dietary risk factors of primary progressive multiple sclerosis: a population-based case-control study. Mult Scler Relat Disord. 2021;56:103233.
  • Yakhdani MF, Mohammadi M, Abargouei AS, Mirzaei M, Rahimdel A, Fathabadi ZA, et al. Dietary food groups and nutrient intake in association with multiple sclerosis: a case-control study. J Environ Health Sustain dev. 2021;6(1):210–1196.
  • Black LJ, Hetherton S, Forkan M, Gonzales EG, Smith JB, Daly A, et al. An exploratory study of diet in childhood and young adulthood and adult-onset multiple sclerosis. Mult Scler. 2021;27(10):1611–4.
  • Orsini N, Li R, Wolk A, Khudyakov P, Spiegelman D. Meta-analysis for linear and nonlinear dose-response relations: examples, an evaluation of approximations, and software. Am J Epidemiol. 2012;175(1):66–73.
  • Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Oxford; 2000.
  • Greene MW, Roberts AP, Frugé AD. Negative association between Mediterranean diet adherence and COVID-19 cases and related deaths in Spain and 23 OECD countries: an ecological study. Front Nutr. 2021;8:591964.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21(11):1539–58.
  • Jackson D, Turner R. Power analysis for random-effects meta-analysis. Res Synth Methods. 2017;8(3):290–302.
  • Berlin JA, Longnecker MP, Greenland S. Meta-analysis of epidemiologic dose-response data. Epidemiology. 1993;4(3):218–28.
  • Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized dose–response data. Stata J. 2006;6(1):40–57.
  • Sterne JA, Sutton AJ, Ioannidis JP, Terrin N, Jones DR, Lau J, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. Br Med J. 2011;343:d4002.
  • Egger M, Smith GD, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. Br Med J. 1997;315(7109):629–34.
  • Hadgkiss EJ, Jelinek GA, Weiland TJ, Pereira NG, Marck CH, van der Meer DM. The association of diet with quality of life, disability, and relapse rate in an international sample of people with multiple sclerosis. Nutr Neurosci. 2015;18(3):125–36.
  • Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, et al. Diet quality is associated with disability and symptom severity in multiple sclerosis. Neurology. 2018;90(1):e1–e11.
  • Maier JAM, Locatelli L, Fedele G, Cazzaniga A, Mazur A. Magnesium and the brain: a focus on neuroinflammation and neurodegeneration. Int J Mol Sci. 2023;24(1):223.
  • Gao F, Ding B, Zhou L, Gao X, Guo H, Xu H. Magnesium sulfate provides neuroprotection in lipopolysaccharide-activated primary microglia by inhibiting NF-κB pathway. J Surg Res. 2013;184(2):944–50.
  • Tai Y, Qiu Y, Bao Z. Magnesium lithospermate B suppresses lipopolysaccharide-induced neuroinflammation in BV2 microglial cells and attenuates neurodegeneration in lipopolysaccharide-injected mice. J Mol Neurosci. 2018;64(1):80–92.
  • Panahi A, Haghayegh SA. Developing the Persian version of Yale food addiction scale and assessing Its psychometric properties. Iranian J Psychiatry Clin Psychol. 2020;25(4):454–71.
  • Tremlett H, Fadrosh DW, Faruqi AA, Zhu F, Hart J, Roalstad S, et al. Gut microbiota in early pediatric multiple sclerosis: a case− control study. Eur J Neurol. 2016;23(8):1308–21.
  • Mao X-Y, Yin X-X, Guan Q-W, Xia Q-X, Yang N, Zhou H-H, et al. Dietary nutrition for neurological disease therapy: current status and future directions. Pharmacol Ther. 2021;226:107861.
  • Riccio P, Rossano R. Nutrition facts in multiple sclerosis. ASN Neuro. 2015;7(1):1759091414568185.
  • Saeedirad Z, Ariyanfar S, Noormohammadi M, Ghorbani Z, Naser Moghadasi A, Shahemi S, et al. Higher dietary acid load might be a potent derivative factor for multiple sclerosis: the results from a case–control study. Nutrients. 2023;15(15):3311.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.